Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DWTXthis companyDogwood Therapeutics, Inc.	$1.17	-0.96×	0.46×	0×	-0.82×	-43.2%	0.0%	0.0%	0.0%	-45.7%	-32.1%	-45.7%	0×	0.19×	0×	2.76×	0.0%	1	-1.2	3	B
BOLTBolt Biotherapeutics, Inc.	$6.35	-0.31×	0.39×	1.33×	-0.67×	-1476.7%	80.6%	-450.1%	-433.7%	-125.9%	-67.7%	-390.3%	0.87×	-0.35×	0×	3.59×	0.0%	2	-18.11	2	C
BRTXBioRestorative Therapies, Inc.	$1.55	-0.75×	29.75×	29.5×	-0.65×	-3282.4%	93.4%	-4350.1%	-3959.4%	-3992.2%	-4386.1%	-102.8%	0×	0.11×	0×	0.84×	0.0%	2	-58.36	2	C+
CLRBCellectar Biosciences, Inc.	$1.31	-0.35×	0.78×	0×	0.24×	259.5%	0.0%	0.0%	0.0%	-219.7%	-222.5%	-300.5%	0.04×	0.59×	0×	2.96×	0.0%	2	-10.78	3	B
COCPCocrystal Pharma, Inc.	$1.05	-1.26×	1.75×	0×	-0.65×	-55.3%	0.0%	0.0%	0.0%	-139.5%	-115.1%	-74.2%	0.24×	0.65×	0×	3.68×	0.0%	3	-108.13	1	C-
ERNAErnexa Therapeutics Inc.	$1.93	-0.54×	3.15×	0×	-0.45×	-4.7%	0.0%	0.0%	0.0%	-586.6%	-316.6%	-93.2%	0.2×	0.1×	-345.15×	1.01×	0.0%	2	-64.61	2	B-
Peer median	—	-0.54×	1.75×	0×	-0.65×	-55.3%	0.0%	0.0%	0.0%	-219.7%	-222.5%	-102.8%	0.2×	0.11×	0×	2.96×	0.0%	2	-58.36	2	—